Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;60(9):479-482.
doi: 10.11622/smedj.2019014. Epub 2019 Feb 18.

Vulvar basal cell carcinoma: clinical features and treatment outcomes from a tertiary care centre

Rama P Namuduri  1 , Timothy Yk Lim  1 , Philip Kl Yam  1 , Rene Gatsinga  2 , Soo Kim Lim-Tan  3 , Sung Hock Chew  3 , Mark Ja Koh  4 , Sorsiah Mansor  3
Affiliations

Vulvar basal cell carcinoma: clinical features and treatment outcomes from a tertiary care centre

Rama P Namuduri et al. Singapore Med J. 2019 Sep.

Abstract

We retrospectively reviewed the clinical features, management and outcomes of patients diagnosed with basal cell carcinoma (BCC) of the vulva at the Gynaecological Cancer Centre, KK Women's and Children's Hospital, Singapore, between 1 January 2000 and 28 February 2014. Patients with vulvar BCC were identified from the cancer registry, and their medical records reviewed and analysed. A total of 11 patients with vulvar BCC were identified. Mean age at diagnosis was 63 (range 30-85) years. Ethnically, ten patients were Chinese and one was Malay. Average time from onset of symptoms to diagnosis was 13.8 (range 2-60) months. The most common presenting symptoms were lump and pruritus. All patients were managed surgically. Recurrence was noted in only one patient. Vulvar BCC, although rare, has an excellent prognosis when managed appropriately. Histological diagnosis of all persistent papules, plaques and pigmented lesions is important for early diagnosis.

Keywords: basal cell carcinoma; neoplasm; vulvar.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Photomicrograph shows well-circumscribed nodules with surrounding loose fibromyxoid stroma and characteristic tumour retraction (arrow) (Haematoxylin & eosin, × 4).
Fig. 2
Fig. 2
Photomicrograph shows tumour arising from the basal layer of the epidermis (Haematoxylin & eosin, × 10).
See this image and copyright information in PMC

Comment in

References

    1. Pisani C, Poggiali S, De Padova L, Andreassi A, Bilenchi R. Basal cell carcinoma of the vulva. J Eur Acad Dermatology Venereol. 2006;20:446–8. - PubMed
    1. Young LC, Listgarten J, Trotter MJ, Andrew SE, Tron VA. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer. Br J Dermatol. 2007;158:59–69. - PubMed
    1. Couvé-Privat S, Bouadjar B, Avril MF, Sarasin A, Daya-Grosjean L. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res. 2002;62:7186–9. - PubMed
    1. Peterson SC, Eberl M, Vagnozzi AN, et al. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell. 2015;16:400–12. - PMC - PubMed
    1. Koh D, Wang H, Lee J, et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin:analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol. 2003;148:1161–6. - PubMed